Glen Industries Ltd
Glen Industries Ltd (GLEN) last reported results for the quarter ended Mar 2026, with sales of ₹108 crore and net profit of ₹8 crore. The stock last traded at ₹117, a market capitalisation of ₹282 crore, on a P/E of 17.1. Over the past 52 weeks the stock has ranged between ₹58 and ₹134. Figures are as of 6 Oct 2026 and are not real time.
Glen Industries Ltd share price and key metrics
- Current price
- ₹117
- Market cap
- ₹282 cr
- Stock P/E
- 17.1
- Book value
- ₹58
- ROE
- 16.6%
- ROCE
- 13.8%
- Dividend yield
- 0.00%
- 52w high / low
- 134/58.0
Metrics as of 6 Oct 2026. Not real time.
Track Glen Industries Ltd
Cruxal reads every Glen Industries Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Glen Industries Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 20%
- TTM
- 20%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 75%
- TTM
- -8%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- 40%
- 10 Years
- %
- 5 Years
- 22%
- 3 Years
- 23%
- Last Year
- 17%
Glen Industries Ltd quarterly results
| ₹ crore | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 84 | 87 | 96 | 108 |
| Expenses | 66 | 64 | 76 | 90 |
| Operating profit | 18 | 23 | 19 | 18 |
| OPM % | 21% | 26% | 20% | 17% |
| Other income | 1 | -0 | 1 | 1 |
| Interest | 4 | 6 | 5 | 5 |
| Depreciation | 4 | 4 | 4 | 4 |
| Profit before tax | 11 | 13 | 11 | 11 |
| Tax % | 25% | 26% | 25% | 23% |
| Net profit | 8 | 10 | 8 | 8 |
| EPS (₹) | 4.84 | 5.53 | 3.45 | 3.41 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Glen Industries Ltd annual results
| ₹ crore | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 92 | 115 | 140 | 166 | 199 |
| Operating profit | 11 | 16 | 25 | 40 | 37 |
| OPM % | 12% | 14% | 18% | 24% | 19% |
| Net profit | 4 | 1 | 9 | 18 | 16 |
| EPS (₹) | 35.62 | 14.42 | 82.46 | 10.37 | 6.86 |
TTM is the trailing twelve months to the most recent quarter.
Glen Industries Ltd balance sheet
| ₹ crore | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity capital | 1 | 1 | 1 | 18 | 32 |
| Reserves | 17 | 31 | 40 | 41 | 107 |
| Borrowings | 77 | 86 | 94 | 133 | 121 |
| Other liabilities | 22 | 19 | 26 | 23 | 30 |
| Total liabilities | 116 | 137 | 161 | 214 | 291 |
| Fixed assets | 55 | 73 | 81 | 108 | 108 |
| CWIP | 1 | 0 | 0 | 1 | 12 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other assets | 60 | 64 | 80 | 106 | 170 |
| Total assets | 116 | 137 | 161 | 214 | 291 |
As reported by the company. Total assets equal total liabilities by construction.
Glen Industries Ltd cash flow
| ₹ crore | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Cash from operations | -14 | 11 | 14 | 6 | 6 |
| Cash from investing | -22 | -15 | -13 | -35 | -18 |
| Cash from financing | 34 | 4 | -2 | 30 | 11 |
| Net cash flow | -2 | 0 | -1 | 1 | -1 |
| Free cash flow | -29 | -2 | 0 | -29 | -14 |
| CFO / operating profit | -124% | 75% | 57% | 20% | 32% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Glen Industries Ltd operating ratios
| Per year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| ROCE % | — | 10% | 15% | 20% | 14% |
| Debtor days | 61 | 52 | 69 | 68 | 68 |
| Inventory days | 192 | 192 | 184 | 252 | 240 |
| Days payable | 34 | 42 | 51 | 25 | 41 |
| Cash conversion cycle | 219 | 202 | 203 | 294 | 267 |
| Working capital days | 6 | -6 | 4 | 4 | 25 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Glen Industries Ltd shareholding pattern
Promoters held 73.31% at Mar 2026, broadly unchanged since Sep 2025. FIIs 0.00% and DIIs 6.64%.
| % held | Sep 2025 | Mar 2026 |
|---|---|---|
| Promoters | 73.00% | 73.31% |
| FIIs | 0.22% | 0.00% |
| DIIs | 9.05% | 6.64% |
| Public | 17.71% | 20.05% |
| No. of shareholders | 1,196 | 1,118 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Glen Industries Ltd corporate filings
- Compliances- Certificate under Reg.74(5) of SEBI (DP) Regulations,2018Company Updatelow impact
- Glen Industries Ltd updates business operations; no financial impact reportedCompany Updatelow impact
Cruxal's analysis: The company has issued a business update under Regulation 30(LODR) on October 6, 2026. No…
Read the full analysis - Glen Industries Ltd schedules analyst/investor meet, no financial or operational updates providedCompany Updatelow impact
Cruxal's analysis: Glen Industries Limited has announced a meeting with analysts and investors scheduled for…
Read the full analysis - Intimation about Closure of Trading Window pursuant to the provisions of SEBI (Prohibition of Insider Trading ) Regulations 2015 for the Half year ended September 30,2026Insider Trading / SASTlow impact
- Glen Industries Ltd publishes routine newspaper notice regarding regulatory complianceCompany Updatelow impact
Cruxal's analysis: Glen Industries Ltd has fulfilled a standard regulatory requirement under Regulation 30…
Read the full analysis - Glen Industries Promoter Group Increases Stake to 74.30% via Open Market AcquisitionsCompany Updatemedium impact
Cruxal's analysis: Glen Industries Limited reported that the Promoter Group, specifically Lalit Agrawal…
Read the full analysis - Glen Industries Limited: Promoter Group Increases Stake to 74.23% via Open Market AcquisitionsCompany Updatelow impact
Cruxal's analysis: Glen Industries Limited has disclosed that the Promoter Group (Lalit Agrawal HUF)…
Read the full analysis - Glen Industries Limited Announces Successful Conclusion of 19th Annual General Meeting and Approval of All ResolutionsAGM/EGMlow impact
Cruxal's analysis: Glen Industries Limited has successfully concluded its 19th Annual General Meeting held…
Read the full analysis - Glen Industries Limited: Promoter Group Increases Stake to 74.21% via Open Market PurchasesCompany Updatemedium impact
Cruxal's analysis: Glen Industries Limited has reported that the Promoter Group, specifically Lalit Agrawal…
Read the full analysis - Glen Industries Limited appoints M/s. Tosniwal & Associates as Joint Statutory Auditor for a five-year termCompany Updatelow impact
Cruxal's analysis: Glen Industries Limited has announced the appointment of M/s. Tosniwal & Associates as…
Read the full analysis - Glen Industries Limited concludes 19th Annual General Meeting; all resolutions passedAGM/EGMlow impact
Cruxal's analysis: Glen Industries Limited has successfully concluded its 19th Annual General Meeting held…
Read the full analysis - Glen Industries Limited: Promoter Group Increases Stake to 74.17% via Open Market AcquisitionsCompany Updatemedium impact
Cruxal's analysis: Glen Industries Limited has reported that the Promoter Group, specifically Lalit Agrawal…
Read the full analysis - Glen Industries Ltd files Regulation 32 Monitoring Agency ReportCompany Updatelow impact
Cruxal's analysis: Glen Industries Ltd has submitted its Regulation 32 Monitoring Agency Report as part of…
Read the full analysis - Glen Industries Limited: Promoter Group Increases Stake to 73.97% via Open Market AcquisitionCompany Updatemedium impact
Cruxal's analysis: Glen Industries Limited has reported that the promoter group, specifically Lalit Agrawal…
Read the full analysis - Glen Industries Limited: Promoter Group Increases Stake to 73.89% via Open Market PurchasesCompany Updatemedium impact
Cruxal's analysis: Glen Industries Limited has reported that the Promoter Group acquired a total of 44,400…
Read the full analysis - Glen Industries Limited: Promoter Group Increases Stake to 73.71% via Open Market AcquisitionCompany Updatemedium impact
Cruxal's analysis: Glen Industries Limited has disclosed that the Promoter Group (Lalit Agrawal HUF)…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.